Back to Online Symposia Home Page
|
|
Learning Objectives
By participating in this activity, you will be able to:
- Explain the challenges in the diagnosis of bipolar disorder and unipolar depression and the impact on clinical outcomes
- Describe bipolar disorder clinical practice guidelines and how to apply these guidelines into clinical practice
- Evaluate the risks/benefits of therapeutic options for bipolar disorder and the importance of neuroprotection
Who Will Benefit
This activity was designed to meet the continuing education needs of psychiatrists and other physicians, physician assistants, registered nurses, psychiatric nurses and advanced practice nurses. Other mental health professionals may find this activity informative and should check with their state licensing and certification boards to determine if it meets their continuing education requirements.
Your Distinguished Faculty
Connecting Neurobiology and Disease in Bipolar Disorder
Jay D. Fawver, MD
Clinical Professor of Psychiatry, Indiana University
President and Medical Director, Fawver Wellness Clinic, Fort Wayne, Ind.
President, Psychiatric Innovations, PC, Fort Wayne, Ind.
Faculty Disclosures
Jay D. Fawver, MD, is a member of the Speakers Bureau for Eli Lilly and Company and Pfizer Inc. He also acts as a consultant for Eli Lilly and Company.
Pharmacologic Management of Bipolar Disorder: Efficacy and Safety
Alan C. Swann, MD
Pat R. Rutherford, Jr., Professor and Vice-Chair for Research, Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston
Faculty Disclosures
Alan C. Swann, MD, has been a member of the Speakers Bureau, acted as a consultant for, and received grants/research support and/or honoraria from Abbott, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Ortho-McNeil Pharmaceutical, Inc., Pfizer, Inc., and sanofi-aventis U.S., Inc.
|
Commercial Support
Supported by an educational grant from Eli Lilly and Company
Disclaimers
The content of this video activity may include product information that is inconsistent with or outside of the approved labeling for these products in the United States. Before prescribing any medication, you must familiarize yourself with the manufacturer's product information.
To earn continuing education credit, view this online course and complete the posttest and evaluation provided. A passing score of 70% or more must be achieved on the posttest. A link is provided within this online activity to access the posttest and evaluation. You will have the option of printing a Statement of Credit for your records after submission of the evaluation.
CME LLC and Eli Lilly and Company are not responsible for the speaker's statements, materials, acts or omissions. |
|
Continuing Medical Education
CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CME credits from activities presented by ACCME accredited providers may be used toward American Osteopathic Association (AOA) Category 2-A requirements.
The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
CME LLC is approved by the California Board of Registered Nursing, Provider No. CEP12748, and designates this educational activity for 1.0 contact hour for nurses.
The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ toward recertification requirements.
Content Originally Presented: October 12, 2007
Online Date: December 17, 2007
Credit Expiration Date: December 16, 2008
This activity is based on the symposium Understanding the Neurobiology of Bipolar Disorder: Focus on Efficacy and Safety at the 20th Annual U.S Psychiatric and Mental Health Congress in October, 2007 in Orlando, Fla. Participants who attended the live symposium mentioned above cannot claim credit for this activity.
|
